New Harvard Schizophrenia Study Initiated - Volunteers Needed
Researchers at Harvard Medical School are studying a new way of treating schizophrenia. Current medications only treat the symptoms of schizophrenia, not the cause. The treatment we are studying may result in a more lasting improvement of symptoms by normalizing a biological process that is thought to be irregular in this disorder. This treatment involves taking an FDA-approved medication, in addition to the subject’s current medication.

We are recruiting subjects who are:
- schizophrenic
- 18-25 years old
- taking risperidone (Risperdal)
- Live in the Boston Area

Compensation up to $250 will be provided to the participants.

For more information, please call Andrea at 617-998-5010

The study will take place in Boston, so participants must live close enough to come in for weekly visits. The study will last approximately 7 months (until sometime in the year 2005). For six months, study participants will be taking the study drug (tiagabine) or placebo. For three months the visits to our office will be weekly, then only once a month for an additional three months. There will also be an MRI scan at the beginning and end of the study. The study is a double-blind, placebo-controlled, add-on design. Participants must be 18-25 years old, schizophrenic, and on risperidone.



   Copyright 1996-2004. All Rights Reserved.